Anti Cancer Medicine
Dactinomycin Injection Supplier Exporter Washington USA
Price on Request
Dactinomycin Injection USP 0.5 mg
Introduction
Dactinomycin Injection USP 0.5 mg is a medicine used to treat cancer (antineoplastic). It is a cytotoxic antibiotic of the actinomycin class. It works by binding to DNA and blocking the production of RNA, which prevents cancer cells from growing and multiplying.
Each vial contains 500 mcg (0.5 mg) of Dactinomycin USP in combination with excipients, including mannitol. It is supplied as a sterile, lyophilized powder, yellow to orange in color, for use in the preparation of intravenous solutions.
Therapeutic Uses / Indications
Dactinomycin Injection is used as part of combination chemotherapy protocols for the treatment of various cancers, including:
Wilms Tumor (Kidney cancer in children)
Rhabdomyosarcoma
Ewing Sarcoma
Gestational Trophoblastic Neoplasia
Metastatic Nonseminomatous Testicular Cancer
Certain locally recurrent or solid tumors as part of regional chemotherapy approaches
Mechanism of Action
Dactinomycin works by:
Binding with DNA strands
Blocking DNA-dependent RNA synthesis
Preventing cancer cell replication
Producing cytotoxic effects against rapidly dividing tumor cells
Key Product Features
✅ Oncology chemotherapy medication
✅ USP grade formulation
✅ Sterile lyophilized powder injection
✅ Single-dose vial presentation
✅ Suitable for hospital and oncology center use
✅ Requires preparation by trained healthcare professionals
Storage condition
Store at a controlled room temperature of 20°C to 25°C (68°F to 77°F).
Humidity and light protection
Handle the reconstituted solution in accordance with healthcare practices and product instructions.
Packaging Details
Packaging Type:
Single-dose vial
Lyophilized powder form
0.5 mg per vial
Contact Ernest Impex — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
Introduction
Dactinomycin Injection USP 0.5 mg is a medicine used to treat cancer (antineoplastic). It is a cytotoxic antibiotic of the actinomycin class. It works by binding to DNA and blocking the production of RNA, which prevents cancer cells from growing and multiplying.
Each vial contains 500 mcg (0.5 mg) of Dactinomycin USP in combination with excipients, including mannitol. It is supplied as a sterile, lyophilized powder, yellow to orange in color, for use in the preparation of intravenous solutions.
Therapeutic Uses / Indications
Dactinomycin Injection is used as part of combination chemotherapy protocols for the treatment of various cancers, including:
Wilms Tumor (Kidney cancer in children)
Rhabdomyosarcoma
Ewing Sarcoma
Gestational Trophoblastic Neoplasia
Metastatic Nonseminomatous Testicular Cancer
Certain locally recurrent or solid tumors as part of regional chemotherapy approaches
Mechanism of Action
Dactinomycin works by:
Binding with DNA strands
Blocking DNA-dependent RNA synthesis
Preventing cancer cell replication
Producing cytotoxic effects against rapidly dividing tumor cells
Key Product Features
✅ Oncology chemotherapy medication
✅ USP grade formulation
✅ Sterile lyophilized powder injection
✅ Single-dose vial presentation
✅ Suitable for hospital and oncology center use
✅ Requires preparation by trained healthcare professionals
Storage condition
Store at a controlled room temperature of 20°C to 25°C (68°F to 77°F).
Humidity and light protection
Handle the reconstituted solution in accordance with healthcare practices and product instructions.
Packaging Details
Packaging Type:
Single-dose vial
Lyophilized powder form
0.5 mg per vial
Contact Ernest Impex — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
Enquire About This Product
